Literature DB >> 28321880

Group O RBCs: where is universal donor blood being used.

R L Barty1, M Pai2, Y Liu1, D M Arnold1,3, R J Cook4, M P Zeller1,3, N M Heddle1,3.   

Abstract

BACKGROUND: There have been recurrent shortages of group O blood due to insufficient inventory and use of group O blood in ABO non-identical recipients. We performed a 12-year retrospective study to determine utilization of group O Rh-positive and Rh-negative red blood cells (RBCs) by recipient ABO group. Reasons for transfusing group O blood to ABO non-identical recipients were also assessed.
METHODS: Utilization data from all group O Rh-positive and Rh-negative RBCs transfused at three academic hospitals between April 2002 and March 2014 were included. Data were extracted from Transfusion Registry for Utilization Surveillance and Tracking, a comprehensive database with inventory information on all blood products received at the hospitals. Extracted data included product type, ABO and Rh, final disposition (transfused, wasted, outdated), and demographic and clinical data on all patients admitted to hospital. Descriptive statistics were performed using sas 9.3.
RESULTS: There were 314 968 RBC transfusions: 151 645 (48·1%) were group O, of which 138 136 (91·1%) RBC units were transfused to group O individuals. ABO non-identical recipients received 13 509 group O RBCs (8·9%). The percentage of group O RBCs transfused to ABO non-identical recipients by fiscal year varied from 7·8% to 11·1% with a steady increase from 2011 to 2013. Reasons for this included: trauma, outdating, outpatient usage and shortages.
CONCLUSION: The practice of transfusing O RBCs to non-O individuals has been increasing. Specific hospital and blood supplier policies could be targeted to change practice, leading to a more sustainable group O red blood cell supply.
© 2017 International Society of Blood Transfusion.

Entities:  

Keywords:  blood group; quality management; red cell components; transfusion medicine

Mesh:

Substances:

Year:  2017        PMID: 28321880     DOI: 10.1111/vox.12492

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  A regional massive hemorrhage protocol developed through a modified Delphi technique.

Authors:  Jeannie L Callum; Calvin H Yeh; Andrew Petrosoniak; Mark J McVey; Stephanie Cope; Troy Thompson; Victoria Chin; Keyvan Karkouti; Avery B Nathens; Kimmo Murto; Suzanne Beno; Jacob Pendergrast; Andrew McDonald; Russell MacDonald; Neill K J Adhikari; Asim Alam; Donald Arnold; Lee Barratt; Andrew Beckett; Sue Brenneman; Hina Razzaq Chaudhry; Allison Collins; Margaret Harvey; Jacinthe Lampron; Clarita Margarido; Amanda McFarlan; Barto Nascimento; Wendy Owens; Menaka Pai; Sandro Rizoli; Theodora Ruijs; Robert Skeate; Teresa Skelton; Michelle Sholzberg; Kelly Syer; Jami-Lynn Viveiros; Josee Theriault; Alan Tinmouth; Rardi Van Heest; Susan White; Michelle Zeller; Katerina Pavenski
Journal:  CMAJ Open       Date:  2019-09-03

2.  Modern Rhesus (Rh) typing in transfusion and pregnancy.

Authors:  Willy Albert Flegel
Journal:  CMAJ       Date:  2021-01-25       Impact factor: 8.262

3. 

Authors:  Willy Albert Flegel
Journal:  CMAJ       Date:  2021-03-29       Impact factor: 8.262

4.  Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost.

Authors:  Noora Obaidallah; Helen Downie; Connie Colavecchia; Jeannie Callum; Yulia Lin
Journal:  Transfusion       Date:  2022-02-25       Impact factor: 3.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.